Skip to content

Analgosedative adjuncT keTAmine Infusion iN Mechanically vENTilated ICU Patients

Adjunct Low Dose Ketamine Infusion Versus Standard of Care in Mechanically Ventilated Critically Ill Patients at a Tertiary Saudi Hospital: Randomized, Prospective, Pilot Trial

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04075006
Acronym
ATTAINMENT
Enrollment
84
Registered
2019-08-30
Start date
2019-08-28
Completion date
2021-05-06
Last updated
2021-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Illness, Mechanical Ventilation, Sedation

Keywords

Ketamine, standard of care, critically ill, mechanically ventilation, ATTAINMENT, propofol, Fentanyl , midazolam , delirium, vasopressors

Brief summary

The purpose of this study is to investigate the efficacy and safety of a low dose ketamine infusion used in combination of standard of care in critically ill patients to test whether ketamine can help to shorten the time of being in breathing tube and ventilator compared to the standard of care alone.

Detailed description

Ketamine is used to produce sedation and relieve pain to minimize discomfort while a breathing tube placed in trachea (windpipe) and a machine (ventilator) used in the ICU. Several publications have shown that a low-dose ketamine in combination to opioids has been used to relieve acute pain after surgery. Ketamine has a favorable characteristics including bronchodilation, increase in blood pressure, does not cause constipation , maintain respiratory reflexes (respiratory spontaneous responses) make it an especially viable alternative for patients with unstable respiratory and hemodynamic function. However, the majority of these trials are conducted in a surgical ICU setting, retrospective in nature or randomized controlled clinical trials focusing on comparison of ketamine to placebo or two study drugs (e.g. ketamine versus opioid), despite the fact that most ICU patients are sedated with a combination of drugs. Moreover, the majority of those trials has a limited focus on patient-centered outcomes, as the primary outcome. The aim of this study is to assess weather ketamine can help to shorten the time of being in breathing tube and ventilator (duration of mechanical ventilation). This is a prospective, randomized, active controlled, open-label pilot study to assess the efficacy and safety of Analgo-sedative adjuncT keTAmine Infusion iN Mechanically vENTilated ICU patients (ATTAINMENT trial). The study hypothesis is that low dose ketamine infusion will reduce the duration of mechanical ventilation with an acceptable safety profile compared to standard of care. The study will include adult ICU patients (\> 14 years old) admitted to KFSHRC ICUs within the previous 24 hours, placed on the ventilator, expected to need breathing tube for longer than 24 hours and placed on KFSHRC sedation and pain protocol. Patients will be separated to 2 groups: The intervention group: will receive a low dose ketamine infusion used in combination of standard of care. Ketamine will be given as intravenous infusion at a fixed infusion rate 0.12 mg/kg/hr (2 µg/kg/min) in 1st 24hr followed by 0.06 mg/kg/hr (1 µg/kg/min) in 2nd 24hr. The control group which will receive standard of care in the ICU including propofol and / or fentanyl and/or midazolam according to KFSHRC ICU sedation and analgesia protocol as chosen by the treating clinician.The randomization process is computer-generated using block randomization with a size of 8 patients in each block. The number of the subjects to be enrolled in this study is 80 and duration of the subject's participation is 48hrs. Patients will be assessed for duration of mechanical ventilation as a primary outcome. Study medication (i.e. ketamine) will be administered until one the following occurs: 1. Patient has received ketamine for 48 hours (intended duration if the study), or 2. If ICU team deemed excessive sedation persisted after holding or decreasing the sedating medication and patient not on target sedation score called RASS, 3. Patient died or goal of care changed to comfort care 4. Patient extubated and sedation weaned off , 5. an adverse event potentially attributable to the study drug is experienced by a patient that is deemed, in the opinion of the investigative team to warrant discontinuation of therapy such as fast heart beat persist \>150 beat per min for more than 3 hours, high systolic blood pressure persist \> 180 for more than 3 hours, severe agitation and pulling off breathing tube or lines, and aggressive behavior to the nursing staff.

Interventions

DRUGKetamine

standard of care plus Ketamine infusion at a fixed rate of 0.12 mg/kg/hr (2 µg/kg/min) in the first 24 hours followed by 0.06 mg/kg/hr (1 µg/kg/min) in the second 24 hours, then discontinued

Sponsors

King Faisal Specialist Hospital & Research Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
14 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Adult ICU (Medical or surgical) patients (\> 14 years old) 2. Mechanically ventilated within the previous 24 hours and expected to remain intubated for more than 24 hours. 3. The patient requires ongoing sedative medication 4. No objection from the ICU attending MD for enrollment

Exclusion criteria

1. Patients with a history of dementia or psychiatric disorders or on any anti-psychotics or anti-depressants medications at home 2. Pregnancy 3. Age \< 14 years old 4. Expected to need mechanical ventilation less than 24 hours 5. Known hypersensitivity to ketamine 6. Patient on dexmedetomidine as primary sedative agent prior to randomization 7. Patients with cardiogenic shock, heart failure, myocardial infarction 8. History of end-stage liver disease. 9. Proven or suspected primary neurological injury (traumatic brain injury, ischemic stroke, intracranial hemorrhage, spinal cord injury, anoxic brain injury) 10. Patients with persistent heart rate (HR) \> 150 bpm or systolic blood pressure (SBP) \>180 mmHg 11. Patients who assigned as do-not-resuscitate order (DNR) or expected to die within 24 hours 12. Patients on ECMO 13. Patients with status epilepticus patients who are receiving the ketamine infusion for refractory status epilepticus 14. Proven or suspected status asthmaticus 15. Patients with expected targeted RASS of -5 such as patients on continuous infusion neuromuscular blockade

Design outcomes

Primary

MeasureTime frameDescription
Duration of Mechanical VentilationFrom Intubation to extubation date and off Mechanical Ventilation or until ICU discharge, death, or 28 days post randomization whichever occurs first.To assess whether ketamine can help to shorten the time of being in breathing tube and ventilator (duration of mechanical ventilation )

Secondary

MeasureTime frameDescription
Vasopressor Medication DosagesFirst 48 hours after randomization.To compare vasopressor requirement.
ICU Length of stay (LOS)Throughout study completion (1 year)To compare ICU LOS
Tracheostomy28 days after randomizationTracheostomy rate
Unplanned extubation28 days after randomizationRate of unplanned extubation
Re-intubation rate28 days after randomizationRate of unplanned and unexpected re-intubation
Cumulative Sedation DosagesFirst 48 hours after randomizationTo compare the cumulative dose of pain and sedative medications.
Dexmedetomidine useFirst 48 hours after randomizationTo compare the number of patients started on dexmedetomidine.
Richmond Agitation Sedation Score (RASS)First 48 hours after randomizationTo compare The number of patients are in RASS score goal.
Pain scoreFirst 48 hours after randomizationTo compare The number of patients are in pain score goal. We will use the KFSHRC pain scale being used in our ICU. For Adult communicative patients, we will use a scale from 0-10. The 0 indicates No pain and 10 indicates severe pain. Values between 1-3 indicate mild pain, values between 4-6 indicate moderate pain while values between 7-10 indicate severe pain. For non-communicative patients, A scale is composed of five categories: Physiology, Facial expressions, Activity (movement), Guarding And Respiratory, will be used. Each Category has a scale 0-2, then the total score is calculated and should be between 0-10. Values between 0-2 indicate no pain, values 3-6 indicate moderate pain while values between 7-10 indicate severe pain.
HemodynamicsFirst 48 hours after randomizationChanges in Mean Arterial Blood Pressure (MAP) and Heart Rate (HR)
Frequency of endotracheal tube SuctioningFirst 48 hours after randomizationProportion of patient with changes in requirements of suctioning frequency to 2 hours of less
Hospital Length of Stay (LOS)Throughout study completion (1 year)To compare hospital LOS

Other

MeasureTime frameDescription
Use of Physical restraints48 hours after randomizationUse of physical restraints
Mortality28 days after randomizationDeath that occurs during 28 days
Incidence of Delirium48 hours after randomizationRate of positive Confusion Assessment Method in Intensive Care Unit (CAM-ICU)
The use of anti-psychotics48 hours after randomizationRate of using anti-psychotics for confirmed ICU-acquired delirium

Countries

Saudi Arabia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026